中文

长华化学 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-28
ItemAmountY/Y
Revenue¥0.67B+16.0%
Gross profit¥0.04B
Operating income¥0.01B
Net income¥0.01B-32.5%
Gross margin6.1%Net margin 1.9%
Revenue Q/Q-12.2%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.63B93.9%
R&D¥0.00B0.7%
SG&A¥0.02B3.6%
Tax & other¥0.00B0.0%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

舜禹股份万邦医药上大股份儒竞科技国际复材多浦乐福赛科技春光集团威马农机浙江华远星宸科技骏鼎达

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies